Patents by Inventor Dileep Bhagwat

Dileep Bhagwat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030212127
    Abstract: Described is a novel approach for treating actinic keratosis which involves the use of urea in a dermatological composition. The urea composition can be included in pre-treatment, treatment and post-treatment steps. Also described are novel topical compositions for the treatment step containing a combination of urea and a pharmaceutical agent for treating actinic keratosis, such as a caustic agent, 5-fluorouracil or a photosensitizing agent.
    Type: Application
    Filed: May 9, 2002
    Publication date: November 13, 2003
    Applicant: Bradley Pharmaceuticals, Inc.
    Inventors: Bradley P. Glassman, Dileep Bhagwat, Daniel Glassman
  • Publication number: 20030198611
    Abstract: A method of treating onychomycosis is described which includes administration of a topical formulation containing an effective amount of urea and an antioxidant to an infected area around a nail of a patient.
    Type: Application
    Filed: April 22, 2002
    Publication date: October 23, 2003
    Applicant: Bradley Pharmaceuticals, Inc.
    Inventors: Bradley P. Glassman, Dileep Bhagwat, Daniel Glassman
  • Publication number: 20030199591
    Abstract: Topical compositions which include urea and carbamide peroxide are described. Compositions having a pH in the acidic range, particularly in the range of about 2.5 to about 9 are also described. Methods for treating dermatological disorders using the composition are also described.
    Type: Application
    Filed: February 26, 2003
    Publication date: October 23, 2003
    Applicant: Bradley Pharmaceuticals, Inc.
    Inventors: Bradley P. Glassman, Dileep Bhagwat, Daniel Glassman
  • Publication number: 20030181526
    Abstract: Methods of treating fungal conditions and onychomycosis are described which include administration of a safe and effective amount of urea in a topical formulation to an affected area on the skin or around a nail of a patient in need of treatment.
    Type: Application
    Filed: February 20, 2003
    Publication date: September 25, 2003
    Applicant: Bradley Pharmaceuticals, Inc.
    Inventors: Dileep Bhagwat, Bradley P. Glassman, Daniel Glassman
  • Publication number: 20030181525
    Abstract: A method of treating onychomycosis is described which includes administration of an effective amount of urea in a topical formulation to an infected area around a nail of a patient.
    Type: Application
    Filed: March 20, 2002
    Publication date: September 25, 2003
    Applicant: Bradley Pharmaceuticals, Inc.
    Inventors: Dileep Bhagwat, Bradley P. Glassman, Daniel Glassman
  • Publication number: 20030165577
    Abstract: Topical compositions which include urea and an antimicrobial agent, particularly sulfacetamide or metronidazole, are described. Sulfacetamide compositions further including sulfur are also described. Methods for treating dermatological disorders using the compositions are also described.
    Type: Application
    Filed: February 11, 2003
    Publication date: September 4, 2003
    Applicant: Bradley Pharmaceuticals, Inc.
    Inventors: Dileep Bhagwat, Bradley P. Glassman, Daniel Glassman
  • Publication number: 20030138466
    Abstract: Enhanced dermatological compositions are described herein using from about 21 to about 40 wt-% urea with antioxidant skin protectants suitable for the treatment of icthyosis, xerosis, severely dry skin, dermatitis, eczema, debridement and tissue suffering and other similar skin conditions.
    Type: Application
    Filed: November 28, 2001
    Publication date: July 24, 2003
    Applicant: Bradley Pharmaceuticals, Inc.
    Inventors: Dileep Bhagwat, Bradley P. Glassman, Daniel Glassman
  • Patent number: 6573301
    Abstract: Topical compositions which include urea and carbamide peroxide are described. Compositions having a pH in the acidic range, particularly in the range of about 2.5 to about 9 are also described. Methods for treating dermatological disorders using the composition are also described.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: June 3, 2003
    Assignee: Bradley Pharmaceuticals, Inc.
    Inventors: Bradley P. Glassman, Dileep Bhagwat, Daniel Glassman
  • Publication number: 20030064969
    Abstract: Topical compositions which include urea and an antimicrobial agent, particularly sulfacetamide, are described. Sulfacetamide compositions further including sulfur are also described. Methods for treating dermatological disorders using the compositions are also described.
    Type: Application
    Filed: May 10, 2002
    Publication date: April 3, 2003
    Applicant: Bradley Pharmaceuticals, Inc.
    Inventors: Dileep Bhagwat, Bradley P. Glassman, Daniel Glassman
  • Publication number: 20030064084
    Abstract: Topical compositions which include urea and benzoyl peroxide are described. Compositions having a pH in the acidic range, particularly in the range of about 4 to about 9 are also described. Methods for treating dermatological disorders using the composition are also described.
    Type: Application
    Filed: September 24, 2001
    Publication date: April 3, 2003
    Applicant: Bradley Pharmaceuticals, Inc.
    Inventors: Dileep Bhagwat, Bradley P. Glassman, Daniel Glassman
  • Patent number: 6537578
    Abstract: This invention is directed to a novel solid matrixed controlled release, oral dosage form where the dosage form contains a therapeutically effective amount of a sulfonylurea or a salt or derivative thereof in the matrix. Further, the use of an aqueous alkalizing medium affords substantially complete bioavailability of the drug from the matrix of the tablet. The core tablets may optionally be coated with a coating material in the range of 2% to 10% with an enteric material or with a water insoluble material like ethyl cellulose.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: March 25, 2003
    Assignee: Penwest Pharmaceuticals Co.
    Inventors: Dileep Bhagwat, Anand R. Baichwal, Donald Diehl, II
  • Patent number: 6495602
    Abstract: Disclosed are compositions of a novel astringent and keratolytic topical pharmaceutical base into which drugs can be incorporated such as for example an anti-pruritic drug and/or an anti-inflammatory drug.
    Type: Grant
    Filed: December 13, 2001
    Date of Patent: December 17, 2002
    Assignee: Bradley Pharmaceuticals, Inc.
    Inventors: Dileep Bhagwat, Daniel Glassman, Brad P. Glassman
  • Patent number: 6429231
    Abstract: Topical compositions which include urea and an antimicrobial agent, particularly sulfacetamide, are described. Sulfacetamide compositions further including sulfur are also described. Methods for treating dermatological disorders using the compositions are also described.
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: August 6, 2002
    Assignee: Bradley Pharmaceuticals, Inc.
    Inventors: Dileep Bhagwat, Bradley P. Glassman, Daniel Glassman
  • Patent number: 6056977
    Abstract: This invention is directed to a novel solid matrixed controlled release, oral dosage form where the dosage form contains a therapeutically effective amount of a sulfonylurea or a salt or derivative thereof in the matrix. Further, the use of an aqueous alkalizing medium affords substantially complete bioavailability of the drug from the matrix of the tablet. The core tablets may optionally be coated with a coating material in the range of 2% to 10% with an enteric material or with a water insoluble material like ethyl cellulose.
    Type: Grant
    Filed: October 15, 1997
    Date of Patent: May 2, 2000
    Assignee: Edward Mendell Co., Inc.
    Inventors: Dileep Bhagwat, Donald Diehl, II, Anand R. Baichwal
  • Patent number: 5716611
    Abstract: Novel topical formulations an anti-microbially effective amount of povidone iodine and a water-washable emollient, as well as, methods for their preparation, are disclosed.
    Type: Grant
    Filed: January 2, 1996
    Date of Patent: February 10, 1998
    Assignee: Euro-Celtique, S.A.
    Inventors: Benjamin Oshlack, Mark Chasin, Richard Sackler, Dileep Bhagwat
  • Patent number: 5126127
    Abstract: Povidone-Iodine (PVP-I) solutions stable according to U.S.P. standards and a method for preparing the same are disclosed. The PVP-I solution includes a microbicidal effective amount of available iodine and an alkalinizing agent in an effective amount to maintain the stability of the solution for a desired shelf-life of the solution when said solution is stored in a substantially nonpermeable container, the solution being non-buffered. In preferred embodiments, the iodophor solution is a microbicidal PVP-I solution for ophthalmic use.
    Type: Grant
    Filed: July 16, 1991
    Date of Patent: June 30, 1992
    Assignee: Euroceltique, S.A.
    Inventors: Dileep Bhagwat, Benjamin Oshlack
  • Patent number: 4996048
    Abstract: Minimizing the leaching of iodine through packaging containing organic iodophor solution, by introducing into the packaging an amount of additional iodide which minimizes leaching of the iodine through the packaging and stabilizes the iodophor solution therein. The iodophor is preferably polyvinylpyrrolidone iodine.
    Type: Grant
    Filed: November 30, 1988
    Date of Patent: February 26, 1991
    Assignee: Euroceltique, S.A.
    Inventors: Dileep Bhagwat, Oliver Iny, Frank Pedi, Jr.